Decades of History Tell Anything: Biotech Near $50 Set to Soar
A cash-generative biotech near $50 is drawing buyers amid a market shift toward defensible healthcare names. Here’s w...
Prepare for your retirement planning by knowing what to ask a financial planner. These key questions will guide your discussions.
18,106 articlesA cash-generative biotech near $50 is drawing buyers amid a market shift toward defensible healthcare names. Here’s w...
Two Harbors Investment Corp. delayed its stockholder meeting again as votes on the CrossCountry Mortgage affiliate sa...
Investors are split as talks on a possible Iran accord fuel optimism and a warning that the iran deal could actually ...
Kenya's High Court halted a U.S. plan to establish a quarantine facility for Americans exposed to Ebola, delaying a $...
Microsoft is pursuing a unifying Copilot hub to combine its AI tools into one experience, with a late-summer 2026 rol...
A single tickers bundles seven YieldMax sleeves into YMAG, pulling in weekly distributions even as persistent NAV dec...
A major liquidity event reshapes the landscape for SmartStop Self Storage REIT and its stakeholders. This deep dive e...
Meta is betting big on subscriptions with Meta One to pair recurring revenue with AI capability. The thing investors ...
A top crypto insider declares a privacy shift is underway. This article breaks down what that could mean for your inv...
A white-hat researcher retrieved 1,003.62 ETH from a 2016 Ethereum ICO contract, reviving debate over early design ch...
VOO faces a delicate setup as rates hover near multi-year highs and the index’s mega-cap tilt looms. Two signals coul...
A near-$150 million Polymarket contract is roiled as traders question payouts after Strategy disclosed BTC sales. The...